Katia Leandro

Katia Leandro


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2021 in International Journal of Food Science
Verified
Journal Article
Open access
PDF file
CACristine Almeida
Cristine Almeida
BPBianca Figueiredo Mendonça Pereira
Bianca Figueiredo Mendonça Pereira
KLKatia Leandro
Katia Leandro
MCMarion Costa
Marion Costa
BSBernardete Ferraz Spisso
Bernardete Ferraz Spisso
CCCarlos Adam Conte-Junior
Carlos Adam Conte-Junior
Infant formulas are an alternative to replace or supplement human milk when breastfeeding is not possible. The knowledge of human milks bioactive compounds and their beneficial effects has attracted the interest of researchers in the field of infant nutrition, as well as researchers of technology and food sciences that seek to improve the nutritional characteristics of infant formulas. Several scientific studies evaluate the optimization of infant formula composition. The bioactive compound inclusion has been used to upgrade the quality and nutrition of infant formulas. In this context, the purpose of this systematic literature review is to assess the scientific evidence of bioactive compounds present in infant formulas (α-lactalbumin, lactoferrin, taurine, milk fat globule membrane, folates, polyamines, long-chain polyunsaturated fatty acids, prebiotics, and probiotics) and their effects on infant nutrition and health. Through previously determined criteria, studies published in the last fifteen years from five different databases were included to identify the advances in the optimization of infant formula composition. Over the last few years, there has been optimization of the infant formula composition, not only to increase the similarities in their content of macro and micronutrients but also to include novel bioactive ingredients with potential health benefits for infants. Although the infant food industry has advanced in the last years, there is no consensus on whether novel bioactive ingredients added to infant formulas have the same functional effects as the compounds found in human milk. Thus, further studies about the impact of bioactive compounds in infant nutrition are fundamental to infant health.

7 June 2020 in Comprehensive Reviews in Food Science and Food Safety
Verified
Journal Article
Open access
PDF file
BPBianca Figueiredo de Mendonça Pereira
Bianca Figueiredo de Mendonça Pereira
CACristine Almeida
Cristine Almeida
KLKatia Leandro
Katia Leandro
MCMarion Costa
Marion Costa
CCCarlos Adam Conte‐Junior
Carlos Adam Conte‐Junior
BSBernardete Ferraz Spisso
Bernardete Ferraz Spisso
Infant formulas are manufactured products to meet specific nutritional requirements for infants. However, infant formulas can contain harmful substances, such as chemical contaminants and residues, normally due to possible contamination of the raw material or from the production chain. Some studies have demonstrated that veterinary drugs, pesticides, mycotoxins, heavy metals, packaging materials, within other chemicals are found in infant formulas from different sources of contamination. It is known that some of these substances can be hepatotoxic, carcinogenic, teratogenic, mutagenic, immunotoxic, contributing to antibiotic resistance, among other detrimental consequences for consumers’ health. The purpose of this review is to assess the scientific evidence concerning the occurrence, sources, and pathways of contamination, as well as the detrimental impacts on infant health due to the possible presence of chemical contaminants and residues in infant formulas. Moreover, strategies to reduce the risk of contamination of infant formulas are presented to ensure the highest standards of quality of infant formulas. The entire infant formula manufacturing process should be monitored and controlled to minimize the risk of contamination during processing, storage, and distribution, besides ensuring the use of raw materials with as low as acceptable levels of harmful substances in order to assure that the final product shall comply with the maximum levels and maximum residue limits, when established, for residues and contaminants in the final product.

CACristine Almeida
Cristine Almeida
DBDiego dos Santos Baião
Diego dos Santos Baião
PRPaloma de Almeida Rodrigues
Paloma de Almeida Rodrigues
TPTatiana Saint Pierre
Tatiana Saint Pierre
RHRachel Ann Hauser-Davis
Rachel Ann Hauser-Davis
CCCarlos Adam Conte-Junior
Carlos Adam Conte-Junior
Children are highly vulnerable to chemical exposure. Thus, metal and metalloid in infant formulas are a concern, although studies in this regard are still relatively scarce. Thus, the presence of aluminum, arsenic, cadmium, tin, mercury, lead, and uranium was investigated in infant formulas marketed in Brazil by inductively coupled plasma mass spectrometry, and the Target Hazard Quotients (THQ) and Target Cancer Risk (TCR) were calculated in to assess the potential risk of toxicity for children who consume these products continuously. Aluminum ranging from 0.432 ± 0.049 to 1.241 ± 0.113 mg·kg−1, arsenic from 0.012 ± 0.009 to 0.034 ± 0.006 mg·kg−1, and tin from 0.007 ± 0.003 to 0.095 ± 0.024 mg·kg−1 were the major elements, while cadmium and uranium were present at the lowest concentrations. According to the THQ, arsenic contents in infant formulas showed a THQ > 1, indicating potential health risk concerns for newborns or children. Minimal carcinogenic risks were observed for the elements considered carcinogenic. Metabolic and nutritional interactions are also discussed. This study indicates the need to improve infant formula surveillance concerning contamination by potentially toxic and carcinogenic elements.

1 June 2009 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
KLKatia Leandro
Katia Leandro
JCJuliana Machado de Carvalho
Juliana Machado de Carvalho
LGLuiz Fernando Giovanelli
Luiz Fernando Giovanelli
JMJosino Costa Moreira
Josino Costa Moreira
Tuberculosis remains a major public health problem, especially in developing countries. Brazil presents the largest number of cases in Latin America and is among the 22 countries considered priorities by the World Health Organization (WHO). The Rio de Janeiro state has the largest number of cases registered in the country. The treatment of patients, commonly, makes use of the drugs isoniazid and rifampicin for six months. This study aimed to develop and validate an electroanalytical methodology, using the technique of differential pulse voltammetry for the determination of these drugs in the associated form, in order to evaluate the quality of medicines distributed in the state of Rio de Janeiro. The potential reduction for the isoniazid and rifampicin were -1.10 and -0.90 V. The developed and validated electroanalytical method presented a linear range of 0.25 to 1.25 mg/L to isoniazid, limits of detection and quantification of 0.05 and 0.14 mg/L, and recovery of 98.2 ± 0.4%; a tracking linear of 0.40 to 2.00 mg/L for rifampicin, with limits of detection and quantification of 0.07 and 0.19 mg/L and recovery of 95.8 ± 0.6%. Six lots of medicines from two pharmaceutical companies were analyzed. Only one of the samples showed unsatisfactory levels of rifampicin.

3 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
CACristine Almeida
Cristine Almeida
DBDiego dos Santos Baião
Diego dos Santos Baião
KLKatia Leandro
Katia Leandro
Vania Margaret Flosi PaschoalinVania Margaret Flosi Paschoalin
Vania Margaret Flosi Paschoalin
MCMarion Costa
Marion Costa
CCCarlos Adam Conte-Junior
Carlos Adam Conte-Junior
Infant formulas, designed to provide similar nutritional composition and performance to human milk, are recommended when breastfeeding is not enough to provide for the nutritional needs of children under 12 months of age. In this context, the present study aimed to assess the protein quality and essential amino acid content of both starting (phase 1) and follow-up (phase 2) formulas from different manufacturers. The chemical amino acid score and protein digestibility corrected by the amino acid score were calculated. The determined protein contents in most formulas were above the maximum limit recommended by FAO and WHO guidelines and at odds with the protein contents declared in the label. All infant formulas contained lactoferrin (0.06 to 0.44 g·100 g−1) and α-lactalbumin (0.02 to 1.34 g·100 g−1) below recommended concentrations, whereas ĸ-casein (8.28 to 12.91 g·100 g−1), α-casein (0.70 to 2.28 g·100 g−1) and β-lactoglobulin (1.32 to 4.19 g·100 g−1) were detected above recommended concentrations. Essential amino acid quantification indicated that threonine, leucine and phenylalanine were the most abundant amino acids found in the investigated infant formulas. In conclusion, infant formulas are still unconforming to nutritional breast milk quality and must be improved in order to follow current global health authority guidelines.

1 November 2018 in Revista de Direito Sanitário
Verified
Journal Article
Open access
PDF file
JSJulia Rodrigues Martins Pastor dos Santos
Julia Rodrigues Martins Pastor dos Santos
AAAndré Luis Mazzei Albert
André Luis Mazzei Albert
KLKatia Leandro
Katia Leandro
This study aims at showing how important is that the Brazilian legislation regulate the term "food supplement", in order to comply with international legislation and the market scenario characterized by constant technological innovations and, consequently, a wide variety of products. Laws and resolutions of the collegiate board are described, which have been published by the Brazilian Health Regulatory Agency for the registration of these products, legally classified as foods. This paper also describes the classifications of international laws and cases of adulteration.